PARIS – Outcomes for women with progressive or relapsed ovarian carcinoma are significantly improving due to the availability of new molecularly tar... More »
Men with favorable intermediate-risk prostate cancer could be considered for active surveillance, say the authors of a study, published in JAMA Oncolo... More »
MAUI, HAWAII – Though costly, newer biologics increase 1-year survival with metastatic melanoma from perhaps 40% to more than 70%.
Among the latest... More »
MAUI, HAWAII – Though costly, newer biologics increase 1-year survival with metastatic melanoma from perhaps 40% to more than 70%.
Among the latest... More »
Adding radiotherapy to androgen-deprivation therapy for locally advanced prostate cancer improves overall survival 30% in the long term, according to ... More »
Utah will have the lowest cancer mortality rate in the United States in 2015, according to a report from the American Cancer Society.
While 11 states... More »
Current, short-term use of hormone replacement therapy led to a 43% increase in risk of serous and endometrioid ovarian cancers, according to a large ... More »
Current, short-term use of hormone replacement therapy led to a 43% increase in risk of serous and endometrioid ovarian cancers, according to a large ... More »
SAN ANTONIO – Patients with stage T1a or T1b triple-negative breast cancer have an excellent prognosis even without chemotherapy, according to Dr. E... More »
SAN ANTONIO – Patients with stage T1a or T1b triple-negative breast cancer have an excellent prognosis even without chemotherapy, according to Dr. E... More »